Higher vitamin D levels may lower breast cancer risk

July 13, 2018

(HealthDay)—Higher levels of vitamin D may be protective against breast cancer, according to a study published online June 15 in PLOS ONE.

Sharon L. McDonnell, M.P.H., from GrassrootsHealth in Encinitas, Calif., and colleagues examined the relationship between 25-hydroxyvitamin D (25[OH]D concentration and across a broad range of 25(OH)D concentrations (<20 to ≥60 ng/mL) among women aged 55 years and older participating in three previous studies (pooled cohort, 5,038 participants).

The researchers found that 77 women were diagnosed with breast cancer (age-adjusted incidence: 512 cases per 100,000 person-years). There was an 82 percent lower incidence rate of breast cancer for women with 25(OH)D concentrations ≥60 versus <20 ng/mL (rate ratio [RR], 0.18; P = 0.006). Kaplan-Meier curves for concentrations of <20, 20 to 39, 40 to 59, and ≥60 ng/mL were significantly different, with the highest proportion of breast cancer-free participants in the ≥60 ng/mL group (99.3 percent) and the lowest proportion of breast cancer-free participants in the <20 ng/mL group (96.8 percent) (P = 0.02). When adjusting for age, body mass index, smoking status, calcium supplement intake, and study of origin, women with 25(OH)D concentrations ≥60 ng/mL had an 80 percent lower risk of breast cancer than women with concentrations <20 ng/mL (hazard ratio, 0.20; P = 0.03).

"Higher 25(OH)D concentrations were associated with a dose-response decrease in risk, with concentrations ≥60 ng/mL being most protective," the authors write.

Bio-Tech Pharmacal, Pure North S'Energy Foundation, and the Vitamin D Society funded the study.

Explore further: Greater levels of vitamin D associated with decreasing risk of breast cancer

More information: Abstract/Full Text

Related Stories

Greater levels of vitamin D associated with decreasing risk of breast cancer

June 15, 2018
Researchers at University of California San Diego School of Medicine suggest higher levels of vitamin D are associated with decreasing risk of breast cancer. Their epidemiological study is published in the June 15 online ...

Vit D concentration associated with reduced risk of cancer

March 14, 2018
(HealthDay)—Higher plasma concentration of 25-hydroxyvitamin D is associated with reduced risk of total cancer in a Japanese population, according to a study published online March 7 in The BMJ.

Increased adiposity tied to lower premenopausal breast CA risk

June 25, 2018
(HealthDay)—Across body mass index (BMI) distribution, increased BMI is associated with reduced risk of premenopausal breast cancer, according to a study published online June 21 in JAMA Oncology.

Large international study links blood vitamin D levels to colorectal cancer risk

June 14, 2018
A new study authored by scientists from the American Cancer Society, the Harvard T.H. Chan School of Public Health, the U.S. National Cancer Institute, and more than 20 other medical centers and organizations finds that higher ...

Higher levels of vitamin D correspond to lower cancer risk, researchers say

April 6, 2016
Researchers at University of California, San Diego School of Medicine report that higher levels of vitamin D - specifically serum 25-hydroxyvitamin D - are associated with a correspondingly reduced risk of cancer. The findings ...

High serum 25(OH)D linked to lower breast cancer mortality

March 14, 2014
(HealthDay)—Higher concentrations of serum 25-hydroxyvitamin D (25[OH]D) are associated with lower mortality from breast cancer, according to a meta-analysis published in the March issue of Anticancer Research.

Recommended for you

What can salad dressing tell us about cancer? Think oil and vinegar

September 20, 2018
Researchers led by St. Jude Children's Research Hospital scientists have identified another way the process that causes oil to form droplets in water may contribute to solid tumors, such as prostate and breast cancer. The ...

Novel biomarker found in ovarian cancer patients can predict response to therapy

September 20, 2018
Despite months of aggressive treatment involving surgery and chemotherapy, about 85 percent of women with high-grade wide-spread ovarian cancer will have a recurrence of their disease. This leads to further treatment, but ...

Cancer immunotherapy might benefit from previously overlooked immune players

September 20, 2018
Cancer immunotherapy—efforts to boost a patient's own immune system, allowing it to better fight cancer cells on its own—has shown great promise for some previously intractable cancers. Yet immunotherapy doesn't work ...

Testing fluorescent tracers used to help surgeons determine edges of breast cancer tumors

September 20, 2018
A team of researchers with members from institutions in The Netherlands and China has conducted a test of fluorescent tracers meant to aid surgeons performing tumor removal in breast cancer patients. In their paper published ...

New way to target advanced breast cancers

September 20, 2018
A cytokine signature found in certain kinds of breast cancer cells can not only serve as a diagnostic tool for HER2-negative cancers but also offer an effective treatment target.

Understanding epilepsy in pediatric tumors

September 20, 2018
Pediatric brain tumors are characterized by frequent complications due to intractable epilepsy compared to adult brain tumors. However, the genetic cause of refractory epilepsy in pediatric brain cancer has not been elucidated ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.